There are 3397 resources available
Discussion
Presenter: All Speakers
Session: YO Masterclass: Tackling new challenges facing young investigators
Resources:
Slides
Webcast
Global access considerations in systemic treatment of genitourinary cancers
Presenter: Fabio Augusto Barros Schutz
Session: Neoadjuvant and adjuvant therapy in genitourinary cancers
Resources:
Slides
Webcast
“Value” and what it really means for new cancer drugs
Presenter: Antonio Fojo
Session: Oncology drug trials: How can we bring true value for patients?
Resources:
Slides
Webcast
Fatigue related to emerging targeted anticancer therapeutics
Presenter: Hope Rugo
Session: In collaboration with the MASCC - The multiple faces of fatigue in the cancer ecosystem
Resources:
Slides
Webcast
Ovarian and rare gynaecological cancers
Presenter: Clare Scott
Session: Molecular profiling of gynaecological cancers for therapeutic stratification
Resources:
Slides
Webcast
IO after or with chemoradiotherapy? For how long?
Presenter: Johan Vansteenkiste
Session: Managing stage III NSCLC in the era of IO
Resources:
Slides
Webcast
Further development of the clinical case: A surgeon’s perspective – Do we still need surgery in the era of risk scores stratification and systemic therapy?
Presenter: Alexander van Akkooi
Session: Early-stage (II/III) melanoma: Risk stratification and treatment decisions
Resources:
Slides
Webcast
Q&A and Discussion
Presenter: All Speakers
Session: Intensification vs descalation of therapy in H&N cancer: When and for whom?
Resources:
Slides
Webcast
Targeted radionuclide therapy for advanced disease/theranostics
Presenter: Jolanta Kunikowska
Session: Advances in our understanding of paraganglioma / pheochromocytoma
Resources:
Slides
Webcast
Predicting response or resistance to IO
Presenter: Giampaolo Bianchini
Session: Finding the positive in triple negative breast cancer
Resources:
Slides
Webcast